Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinuclidine derivatives as muscarinic M3 receptor antagonists

Quinuclidine derivatives as muscarinic M3 receptor antagonists

US Patent 8329729 · Granted Dec 11, 2012

Estimated economic value: $5,401,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tetrahydropyridopyrimidine derivatives as AhR modulators2025
Potassium channel inhibitors2024
Potassium channel inhibitors2024
Heterocyclyl substituted pyrrolopyridines that are inhibitors of the CDK12 kinas2022
Potassium channel inhibitors2022
Potassium channel inhibitors2021
Potassium channel inhibitors2021
Separation of enantiomers of 3-ethylbicyclo[3.2.0]hept-3-en-6-one2018
Cyclic depsipeptide compounds and their uses2018
Cyclic depsipeptide compounds and their uses2016
Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarin2012
Quiniclidine derivatives of (hetero) arylcycloheptanecarboxylic acid as muscarin2012